Trial intelligence / Profile preview

Crystalloid versus colloid for goal directed haemodynamic optimisation in major abdominal cancer surgery

2013-002217-36Phase 4Completed

Sponsor: University Hospital Odense
Start: Jun 2013
Modality: Recombinant Proteins and Enzymes, Device-based Delivery → Drug Delivery Systems
Countries: 1

Overview

Phase 4, randomised trial in pancreatic cancer (PC), gastric cancer (GC) and esophageal cancer comparing Colloid (Human Albumin) arm with Crystalloid (Ringerfundin) arm (2 arms). Primary endpoints: Intraoperative global oxygen delivery (DO2) and Intraoperative local mesenteric oxygen delivery (mDO2). Started Jun 2013; status: completed.

Drugs

albumin (human)Ringerfundin

Conditions

pancreatic cancer (PC)gastric cancer (GC)esophageal cancer

Beyond the preview

Go deeper on 2013-002217-36.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2013-002217-36.